Publications Database

Akhondzadeh S. et al. (2010)

Double-blind placebo controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism.

Progress in Neuro-Psychopharmacology and Biological Psychiatry

34(1), pp. 32-36

Read Abstract (New Window)

Asadabadi M. et al. (2013)

Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.

Psychopharmacology (Berl)

225(1), pp. 51-59.

Read Abstract (New Window)

Ghanizadeh A. , Sahraeizadeh A. , Berk M. (2014)

A head-to-head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trial.

Child Psychiatry and Human Development

45(2), pp. 185-192.

Read Abstract (New Window)

Ghanizadeh A. (2008)

A preliminary study on screening prevalence of pervasive developmental disorder in schoolchildren in Iran.

Journal of Autism and Developmental Disorders

April, 38(4), pp. 759-763

Read Abstract (New Window)

Ghanizadeh A. , Moghimi-Sarani E. (2013)

A randomized double blind placebo controlled clinical trial of N-acetylcysteine added to risperidone for treating autistic disorders.

BMC Psychiatry

13(1), pp. 196.

Read Abstract (New Window) Read Full (New Window)

Ghanizadeh A. , Tordjman S. , Jaafari N. (2015)

Aripiprazole for treating irritability in children and adolescents with autism: A systematic review.

Indian Journal of Medical Research

September, 142(3), pp. 269-275.

Read Abstract (New Window) Read Full (New Window)

Ghanizadeh A. (2013)

Atomoxetine for treating ADHD symptoms in autism: A systematic review.

Journal of Attention Disorders

17(8), pp. 635-640.

Read Abstract (New Window)

Ghanizadeh A. , Berk M. (2015)

Beta-lactam antibiotics as a possible novel therapy for managing epilepsy and autism, a case report and review of literature.

Iranian Journal of Child Neurology

Winter, 9(1),

Read Abstract (New Window) Read Full (New Window)

Ghanizadeh A. (2011)

c-Kit+ cells transplantation as a new treatment for autism: a novel hypothesis with important research and clinical implication.

Journal of Autism and Developmental Disorders

41(11), pp. 1591-1592.

Read Full (New Window)

Ghanizadeh A. (2009)

Does risperidone improve hyperacusia in children with autism?

Psychopharmacology Bulletin

42(1), pp. 108-110

Read Abstract (New Window)

Ghanizadeh A. (2012)

Hyperbaric oxygen therapy for treatment of children with autism: a systematic review of randomized trials.

Medical Gas Research

2(13),

Read Abstract (New Window) Read Full (New Window)

Ghanizadeh A. , Derakhshan N. (2012)

N-acetylcysteine for treatment of autism, a case report.

Journal of Research in Medical Sciences

17(10), pp. 985-987.

Read Abstract (New Window)

Ghanizadeh A. (2008)

Should tactile sensation impairment be considered in pharmacotherapy of pervasive developmental disorders? A case report.

Neuroendocrinology Letters

29(6), pp. 877-878

Read Abstract (New Window)

Ghanizadeh A. (2010)

Targeting neurotensin as a potential novel approach for the treatment of autism.

Journal of Neuroinflammation

(7), pp. 58

Read Abstract (New Window) Read Full (New Window)

Ghanizadeh A. (2011)

Targeting of glycine site on NMDA receptor as a possible new strategy for autism treatment.

Neurochemical Research

36(5), pp. 922-923.

Read Abstract (New Window)

Rezaei V. et al. (2010)

Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.

Progress in Neuro-Psychopharmacology and Biological Psychiatry

34(7), pp. 1269-1272.

Read Abstract (New Window)

Sotoodeh M. S. et al. (2017)

Effectiveness of yoga training program on the severity of autism.

Complementary Therapies in Clinical Practice

August, 28 pp. 47-53.

Read Abstract (New Window)